Colony Family Offices LLC increased its holdings in GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report) by 5.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 512,289 shares of the company’s stock after purchasing an additional 25,190 shares during the period. GMO U.S. Quality ETF makes up about 4.7% of Colony Family Offices LLC’s investment portfolio, making the stock its 7th largest position. Colony Family Offices LLC’s holdings in GMO U.S. Quality ETF were worth $21,346,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Sunbelt Securities Inc. raised its stake in GMO U.S. Quality ETF by 3.8% during the first quarter. Sunbelt Securities Inc. now owns 6,765 shares of the company’s stock valued at $245,000 after purchasing an additional 250 shares in the last quarter. KFG Wealth Management LLC grew its stake in shares of GMO U.S. Quality ETF by 3.3% in the 2nd quarter. KFG Wealth Management LLC now owns 10,607 shares of the company’s stock worth $441,000 after buying an additional 342 shares in the last quarter. Royal Bank of Canada grew its stake in shares of GMO U.S. Quality ETF by 174.5% in the 1st quarter. Royal Bank of Canada now owns 1,268 shares of the company’s stock worth $45,000 after buying an additional 806 shares in the last quarter. Aspen Investment Management Inc increased its holdings in shares of GMO U.S. Quality ETF by 4.6% in the 1st quarter. Aspen Investment Management Inc now owns 27,800 shares of the company’s stock worth $1,006,000 after buying an additional 1,210 shares during the last quarter. Finally, Arete Wealth Advisors LLC increased its holdings in shares of GMO U.S. Quality ETF by 4.6% in the 1st quarter. Arete Wealth Advisors LLC now owns 40,475 shares of the company’s stock worth $1,465,000 after buying an additional 1,785 shares during the last quarter. Hedge funds and other institutional investors own 85.37% of the company’s stock.
GMO U.S. Quality ETF Trading Down 1.0%
Shares of NYSEARCA QLTY opened at $42.60 on Wednesday. GMO U.S. Quality ETF has a 12-month low of $35.15 and a 12-month high of $43.70. The firm’s 50-day moving average price is $42.32 and its 200-day moving average price is $40.32. The stock has a market capitalization of $4.95 billion, a price-to-earnings ratio of 59.17 and a beta of 0.97.
GMO U.S. Quality ETF Increases Dividend
GMO U.S. Quality ETF Company Profile
The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.
Read More
- Five stocks we like better than GMO U.S. Quality ETF
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding QLTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report).
Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.
